Related Experiment Videos
[Deep brain stimulation(DBS) therapy for parkkinson,s disease].
1Department of Neurosurgery, Nihon University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 9, 2000
Summary
Deep brain stimulation (DBS) effectively manages Parkinson's disease symptoms like tremor, rigidity, and bradykinesia. DBS also reduces levodopa side effects, improving patients' daily activities.
Area of Science:
- Neurology
- Neurosurgery
Context:
- Parkinson's disease (PD) presents significant motor challenges.
- Deep brain stimulation (DBS) has emerged as a key therapeutic option.
- Various brain targets are utilized for DBS, including the thalamic nucleus ventralis intermedius (Vim), globus pallidus internus (GPi), and subthalamic nucleus (STN).
Purpose:
- To review current clinical data on DBS for Parkinson's disease.
- To summarize findings from a double-blind evaluation of GPi and STN stimulation.
- To assess the efficacy of DBS in managing specific PD motor symptoms and levodopa-induced complications.
Summary:
- DBS effectively treats tremor when targeting the Vim.
- Rigidity and bradykinesia show improvement with GPi or STN stimulation.
- DBS significantly attenuates dopa-induced dyskinesia by modulating levodopa's effects and allowing dose reduction.
- GPi and STN stimulation supplement levodopa during 'off' periods and replace its action during 'on' periods, improving motor fluctuations and managing dopa-intolerant patients.
Impact:
- DBS offers a valuable therapeutic strategy for Parkinson's disease patients.
- Targeted DBS can enhance motor function and reduce medication-related side effects.
- Improved management of motor fluctuations and dyskinesia leads to better daily functioning and quality of life for PD patients.